CLINICAL_TRIALS
trial_result
· 2021-01-26
Clinical Trial Update: AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) [Phase 2]
Summary
Phase 2 clinical trial update for AARDVARK evaluating ACE-inhibition effects on abdominal aortic aneurysm dilation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Abdominal Aortic Aneurysm | Phase 2 | Status: COMPLETED | Results posted: 2021-01-26